INTRODUCTION
The incidence of hypertensive disorders such as pre-eclampsia and eclampsia in pregnancy is relatively high worldwide. These disorders are considered among the main obstetrical causes for maternal death during pregnancy. 1 2 There are several proposed mechanisms regarding the pathogenesis of pre-eclampsia, most of them involve the placenta as a central organ for the development of this disorder with placental-derived soluble factor that influence the systemic vascular system. 3 4 In recent years, there is a growing interest regarding the link between pre-eclampsia and future risk for atherosclerotic morbidity including both cardiovascular [5] [6] [7] [8] [9] [10] [11] and renal [12] [13] [14] morbidity. Previous studies have described the link between a history of pre-eclampsia and future risk of cardiovascular morbidity and mortality. 5-7 9 This evidence led the American Heart Association to include a history of pre-eclampsia as a risk factor in the guidelines for the preliminary risk evaluation for cardiovascular disease (CVD) in women. 15 Data regarding the link between pre-eclampsia and future risk for renal morbidity are not that well established. 13 14 Also, it is not clear whether a 'dose-response' association exists between the severity of the condition and the number of episodes of pre-eclampsia and the risk for CVD and renal morbidity later in the non-pregnant life.
The objective of the present population-based study was to investigate whether a history of preeclampsia is an independent risk factor for subsequent long-term atherosclerotic morbidity (cardiovascular and renal) in women. We also wanted to investigate whether this risk is increased if a patient had a history of several episodes of pre-eclampsia or had more severe disease.
MATERIALS AND METHODS Setting
The study was conducted at the Soroka University Medical Center, the sole hospital of the Negev, the southern region of Israel, serving the entire population in this region and where all deliveries take place (the annual average of deliveries during the study period was approximately 12 000-15 000 deliveries).
Study population
The study population comprised all patients who delivered between the years 1988 and 2012; follow-up period in non-pregnant life was until 2012. Patients with multiple pregnancies, with known cardiovascular and renal disease before or during the index pregnancy, and patients with known congenital cardiac or renal malformations were excluded from the study.
Study design
A population-based retrospective cohort study was conducted. The primary exposure was having had at least one pregnancy complicated with pre-eclampsia, all other patients served as the comparison group. A retrospective follow-up of hospitalisations due to atherosclerotic morbidity up to 24 years after the index birth was performed. Atherosclerotic morbidity was defined as the first hospitalisations for any cardiovascular and renal indication at Soroka University Medical Center. Cardiovascular morbidity was divided into four categories according to severity and type, including simple and complex cardiovascular events (eg, angina pectoris and congestive heart failure, respectively), and invasive and non-invasive cardiac procedures (eg, insertion of a stent and a treadmill stress test, respectively). The International Classification of Diseases (ICD) codes for each subtype of cardiovascular and renal morbidity are presented in the online supplementary tables S1 and S2.
Data were collected from two databases that were cross-linked and merged: the computerised perinatal database and the computerised hospitalisation database of the Soroka University Medical Center. The perinatal database consists of information recorded directly after delivery by an obstetrician. Skilled medical secretaries routinely review the information prior to entering it into the database. Coding was performed after assessing medical prenatal care records together with the routine hospital documents. The hospitalisation database includes demographic information and ICD 9 codes for all medical diagnoses made during hospitalisations.
Statistical analysis
Statistical analysis was performed using the SPSS package 17 edition (SPSS, Chicago, Illinois, USA). Statistical significance was calculated using χ 2 test for differences in qualitative variables and Student t test for differences in continuous variables. The association between the number and severity of previous events and the risk for subsequent atherosclerotic cardiovascular hospitalisations was evaluated using χ 2 test for trend (the linear-by-linear association test).
Kaplan-Meier survival curves were used to compare cumulative incidence of cardiovascular hospitalisations. Cox proportional hazards models were used to estimate the adjusted HRs and 95% CIs for long-term cardiovascular hospitalisations. p<0.05 was considered statistically significant.
RESULTS
During the study period, 96 370 parturient met the inclusion criteria; 7824 (8.1%) occurred in women who were diagnosed at least once with pre-eclampsia. Table 1 summarises characteristics of the patients with and without a diagnosis of pre-eclampsia. At the index birth, patients in the pre-eclampsia group were significantly older, had a higher birth order and were more likely to be obese and had higher rates of other pregnancy complications such as diabetes mellitus, postpartum anaemia, small for gestational age, antepartum fetal death and placental abruption. The mean number of years of follow-up to the atherosclerotic hospitalisation was significantly shorter in the pre-eclampsia group compared with the comparison group. Table 2 presents a comparison of cardiovascular and renal morbidity and hospitalisations during the follow-up period. Patients with pre-eclampsia had higher rates of renal morbidity in addition to cardiovascular morbidity, including cardiac invasive and non-invasive diagnostic procedures, simple as well as complex cardiovascular events, and hospitalisations due to cardiovascular causes. Table 3 presents a comparison between the incidence of renal and cardiovascular morbidity in women with no history of preeclampsia to women with a history of one pregnancy with preeclampsia and women with two or more pregnancies with a diagnosis of pre-eclampsia. The risk for renal-related and cardiovascular-related hospitalisations including total cardiovascular hospitalisations increased linearly and with statistically significance with the number of past events. Table 4 presents a comparison between the incidence of renal and cardiovascular morbidity according to the severity of preeclampsia. The risk for future renal and cardiovascular morbidity including cardiac invasive and non-invasive diagnostic procedures, simple as well as complex cardiovascular events, and hospitalisations due to cardiovascular causes increased linearly with the severity of the disease (mild pre-eclampsia vs severe pre-eclampsia vs eclampsia). Figure 1 presents Kaplan-Meier survival curves for the cumulative incidence of cardiovascular (a) and renal (b) hospitalisations following the index birth in both study groups ( pre-eclampsia and no pre-eclampsia). Patients with a history of pre-eclampsia had a significantly higher risk for cumulative cardiovascular and renal events during the whole follow-up period.
Cox proportional hazards models were used to estimate the adjusted HRs and 95% CI for long-term cardiovascular (table 5) and renal hospitalisations (table 6). After controlling for maternal age, parity and recognised confounders related to the metabolic syndrome such as diabetes and obesity, pre-eclampsia remained independently associated with cardiovascular-related and renalrelated hospitalisations.
DISCUSSION
The results of the current study further establish the association between a history of pre-eclampsia and future risk for renal as well as cardiovascular-related morbidity and hospitalisations. Furthermore, a significance linear association exists between the number of past preeclampsia episodes and in addition the severity of the disease to the appearance of CVD and renal morbidity later in life.
The results of our study add to the data from other studies regarding the relationship between pre-eclampsia and future risk for cardiovascular morbidity.
5-7 9 Irgens et al 5 studied a registry of 626 727 births and compared mothers with and without a history of pre-eclampsia. They found women with a history of pre-eclampsia to be at higher risk for cardiovascular-related mortality. 5 Shalom et al 6 found a history of pre-eclampsia to be a significant risk factor for long-term morbidity such as chronic hypertension and general hospitalisations. 6 Likewise, Mangos et al 7 studied patients with a history of pre-eclampsia or gestational hypertension and found biochemical evidence predisposing them to later cardiovascular complications. 7 Hashemi et al 9 studied a cohort of 226 patients with a history of hypertensive disorders of pregnancy and 226 matched women. They found patients with a history of pre-eclampsia to be at increased risk for hypertension, diabetes mellitus and dyslipidemia later in non-pregnant life. 9 In the current study, we performed further categorisation of the cardiovascular complications according to ICD codes. This analysis emphasises the importance of a previous history of pre-eclampsia as a risk factor for not only the end point of cardiovascular-related hospitalisations, but also for simple as well as complex morbidity and diagnostic procedures.
In addition, to the best of our knowledge, this is the first study to investigate not only the relationship between a previous diagnosis of pre-eclampsia but also whether a correlation exists between the number of events or severity of the disease to the future risk for cardiovascular-related morbidity and hospitalisations. Future risk for atherosclerotic morbidity is increased linearly with the number of past pregnancies with a diagnosis of pre-eclampsia and also with the severity of the disease. This information is of major importance when counselling future risk for cardiovascular and renal morbidity in patients with previous episodes of pre-eclampsia. Furthermore, in our study, we investigated the link between pre-eclampsia and future risk for renal-related hospitalisations. Previous published data regarding the association between preeclampsia and long-term renal morbidity are relatively scarce and the studies are limited by the low prevalence of renal disorders and thus small sample size. In a review by McDonald et al, 13 only seven cohort studies with a total of 273 patients were found. Patients with a history of pre-eclampsia were found to be at an eightfold increased risk for microalbuminuria. 13 Recently, Wu et al 14 studied a database of 13 633 women with a maximum follow-up of 11 years and found 46 women with a diagnosis of end-stage renal disease. The authors found patients with a history of pre-eclampsia to be at 10 times greater risk for end-stage renal disease.
14 According to the results of our study, patients with a previous diagnosis of pre-eclampsia were at a higher risk for renal-related hospitalisations even after controlling for maternal age and other confounders known to be related to the metabolic syndrome. Furthermore, a linear correlation was noted between renal morbidity and the number of past events as well as the severity of the disease (same as with CVD).
In a study by Heidrich et al, 16 the authors performed a survey to assess physicians' knowledge regarding the long-term risk for CVD after pre-eclampsia. The authors concluded that while the majority of physicians were aware of the risk, weaknesses existed in the follow-up and consultations of these patients. 16 In another study by Cusimano et al, 17 women with common obstetric complications were referred to a clinic for complete lifetime risk assessment for CVD. The authors suggest that this assessment identifies postpartum patients susceptible for CVD and may be effective for primary prevention strategy. 17 The main strength of the present study lies in the fact that our hospital is the sole hospital serving the entire population of southern Israel. The hospital provides both maternity services and tertiary cardiovascular and renal medical services, thus as long as patients live in the area they would only use this hospital. However, the ascertainment of cardiovascular events, which occurred outside of the hospital, could not be accomplished. It is therefore possible that some cardiovascular/renal events were missed, but there is no reason to suspect differential rates of outcome ascertainment in the two study groups.
In conclusion, our results establish that pre-eclampsia is an independent risk factor for subsequent long-term atherosclerotic complications including cardiovascular and renal complications requiring hospitalisations. 
